CRIS Current Research Information System

BELLUZZI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.572
EU - Europa 2.409
AS - Asia 553
AF - Africa 122
SA - Sud America 14
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 3
Totale 5.686
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.551
IT - Italia 877
SE - Svezia 445
GB - Regno Unito 366
DE - Germania 208
CN - Cina 165
IE - Irlanda 124
VN - Vietnam 113
IN - India 103
SG - Singapore 89
FR - Francia 65
UA - Ucraina 60
TG - Togo 48
BG - Bulgaria 47
CH - Svizzera 47
RU - Federazione Russa 44
JO - Giordania 43
CI - Costa d'Avorio 40
EE - Estonia 26
ZA - Sudafrica 25
BE - Belgio 17
CA - Canada 16
AT - Austria 15
FI - Finlandia 14
AU - Australia 13
IR - Iran 13
BR - Brasile 9
GR - Grecia 9
NL - Olanda 9
ES - Italia 8
RO - Romania 7
HR - Croazia 5
SA - Arabia Saudita 5
CL - Cile 4
MU - Mauritius 4
NG - Nigeria 4
TR - Turchia 4
UZ - Uzbekistan 4
BA - Bosnia-Erzegovina 3
BZ - Belize 3
HU - Ungheria 3
LB - Libano 3
AE - Emirati Arabi Uniti 2
DK - Danimarca 2
EU - Europa 2
HK - Hong Kong 2
HN - Honduras 2
PK - Pakistan 2
PT - Portogallo 2
SM - San Marino 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
EG - Egitto 1
ID - Indonesia 1
IL - Israele 1
KR - Corea 1
LK - Sri Lanka 1
MY - Malesia 1
NO - Norvegia 1
PE - Perù 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 5.686
Salva come PNG Salva come JPEG
Città #
Chandler 408
Southend 313
Fairfield 246
Houston 234
Ashburn 214
Princeton 123
Seattle 121
Dublin 118
Bologna 115
Ann Arbor 105
Woodbridge 102
Cambridge 86
Wilmington 85
Singapore 70
Berlin 50
Dong Ket 49
Lomé 48
Sofia 43
Amman 42
Abidjan 40
Bern 34
Rome 34
Milan 33
Turin 31
Westminster 30
Padova 26
Nanjing 25
New York 23
San Diego 21
Beijing 18
Jinan 18
Boardman 17
Hebei 14
Los Angeles 14
Redmond 13
Helsinki 12
Jiaxing 12
Napoli 12
Pune 12
Saint Petersburg 12
Shenyang 12
Des Moines 11
Toronto 11
Brussels 10
Dearborn 10
Redwood City 10
Vienna 10
Bremen 9
Changsha 9
Olalla 9
Buffalo 8
Falls Church 8
Florence 8
Guangzhou 8
Haikou 7
Phoenix 7
San Francisco 7
Washington 7
Capaccio 6
Chicago 6
Ferrara 6
Hyderabad 6
Jacksonville 6
Modena 6
Naples 6
Norwalk 6
Parma 6
Perugia 6
Rimini 6
Sydney 6
Tehran 6
Tianjin 6
Boydton 5
Cesenatico 5
Frankfurt am Main 5
Medford 5
Paris 5
Pesaro 5
Anagni 4
Andover 4
Benevento 4
Caserta 4
Castel Maggiore 4
Catania 4
Genoa 4
Henderson 4
Kunming 4
Lausanne 4
Menaggio 4
Nanchang 4
Nuremberg 4
San Mateo 4
São Paulo 4
Zhengzhou 4
Abeokuta 3
Amsterdam 3
Atlanta 3
Belize City 3
Brescia 3
Budapest 3
Totale 3.380
Salva come PNG Salva come JPEG
Nome #
Polifenoli ed efficacia antinfiammatoria: lo strano caso del melograno e le malattie croniche intestinali 544
Risposta immunitaria verso Mycobacterium avium paratubercolosis (MAP) in pazienti affetti da Morbo di Crohn 240
Pomegranate: from the Promised Land to calm the fire in Inflammatory Bowel Disease 221
COVID-19 in IBD: The experience of a single tertiary IBD center 194
Inflammation increases NOTCH1 activity via MMP9 and is counteracted by Eicosapentaenoic Acid-free fatty acid in colon cancer cells 169
Clinical application of faecal calprotectin in ulcerative colitis patients 165
Short-term treatment with eicosapentaenoic acid improves inflammation and affects colonic differentiation markers and microbiota in patients with ulcerative colitis 162
Isolation of stem cell populations with trophic and immunoregulatory functions from human intestinal tissues: potential for cell therapy in inflammatory bowel disease. 160
Pomegranate juice to reduce fecal calprotectin levels in inflammatory bowel disease patients with a high risk of clinical relapse: Study protocol for a randomized controlled trial 157
Can POSSUM accurately predict post-operative complications risk in patients with abdominal Crohn’s disease? 146
IL23R, NOD2/CARD15, ATG16L1 and PHOX2B polymorphisms in a group of patients with Crohn's disease and correlation with sub-phenotypes. 145
A Mediterranean Diet Mix Has Chemopreventive Effects in a Murine Model of Colorectal Cancer Modulating Apoptosis and the Gut Microbiota 144
Intestinal epithelial cells in inflammatory bowel diseases 142
Highly Purified Eicosapentaenoic Acid as Free Fatty Acids Strongly Suppresses Polyps in ApcMin/+ Mice 139
null 139
Retention Rate, Persistence and Safety of Adalimumab in Inflammatory Bowel Disease: A Real-Life, 9-Year, Single-Center Experience in Italy 139
Eicosapentaenoic Acid Reduces Fecal Levels of Calprotectin and Prevents Relapse in Patients With Ulcerative Colitis 134
Mycobacterium avium subspecies paratuberculosis in the etiology of Crohn’s disease, cause or epiphenomenon? 132
New Insight and Knowledge on anti-inflammatory Effectiveness of dietary phenolics: a work-in-progress report of the NIKE Project 127
Inflammatory bowel disease: Moving toward a stem cell-based therapy 125
Attachment and mentalizing abilities in patients with inflammatory bowel disease 123
Eicosapentaenoic acid free fatty acid prevents and suppresses colonic neoplasia in colitis-associated colorectal cancer acting on Notch signaling and gut microbiota 121
Pilot study: the use of sulfasalazine for the treatment of acute pouchitis. 121
Sulfasalazine in Prevention of Pouchitis After Proctocolectomy with Ileal Pouch–Anal Anastomosis for Ulcerative Colitis 118
New proteomic approaches for biomarker discovery in inflammatory bowel disease 108
New Insight and Knowledge on anti-inflammatory Effectiveness of dietary phenolics: the NIKE Project 101
Aortic thrombosis recurrence in a Crohn's disease patient 97
null 95
A proposed staging system and stage-specific interventions for familial adenomatous polyposis 95
5-Aminosalicylic acid in patients with ulcerative colitis in remission: plasma levels after administration of a new rectal enema 83
Eicosapentaenoic free fatty acid to treat patients with SARS-Cov2 infection 77
PROBABILISTIC ASSESSMENT OF SYMPTOMLESS INFLAMMATION IN CROHN’S DISEASE PATIENTS 74
5-Aminosalicylic acid suppositories in the management of ulcerative colitis 69
The Effect of Supplementing a Novel n-3 Polyunsaturated Fatty Acids Formulation Containing Schisandra chinensis Extract and Vitamin D3 to a Group of Elite Sport Athletes on Competition Related Stress, Anxiety and Self-confidence 68
5-Aminosalicylic acid as enemas or suppositories in distal ulcerative colitis? 60
Analysis of biological variables in Crohn's disease [4] 53
[Abdominal scintigraphy with leukocytes marked with indium-111 in Crohn disease: clinical importance and prognostic usefulness] 53
Bioavailability of single and multiple doses of a new oral formulation of 5‐ASA in patients with inflammatory bowel disease and healthy volunteers 48
Baseline Histological Findings Do Not Predict the Risk of Subsequent Extension in Patients with Limited Ulcerative Colitis 47
Topical administration of 5-aminosalicylic acid enemas in patients with ulcerative colitis. Studies on rectal absorption and excretion 46
Efficacy of 5-aminosalicylic acid enemas versus hydrocortisone enemas in ulcerative colitis 45
Effects of new fish oil derivative on fatty acid phospholipid-membrane pattern in a group of Crohn's disease patients 39
Macrophage subpopulations in pouchitis 39
Respiratory burst of circulating polymorphonuclear leukocytes and plasma elastase levels in patients with inflammatory bowel disease in remission 38
Influence of steroid treatment's duration in patients with active Crohn's disease 38
Scavenger effect of sulphasalazine (SASP), 5-aminosalicylic acid (5-ASA), and olsalazine (OAZ) (I) 37
Scavenger effect of sulfasalazine, 5-aminosalicylic acid, and olsalazine on superoxide radical generation 34
Optimum dosage of 5-Aminosalicylic acid as rectal enemas in patients with active ulcerative colitis 33
Bronchopulmonary involvement in ulcerative colitis 33
Role of rectal formulations: Enemas 32
Requirements for the use of intestinal action antibiotics in the treatment of ulcerative colitis 32
A combination of eicosapentaenoic acid-free fatty acid, epigallocatechin-3-gallate and proanthocyanidins has a strong effect on mTOR signaling in colorectal cancer cells. 31
Enhanced mucosal interleukin-6 and -8 in Helicobacter pylori-positive dyspeptic patients 30
Interleukin 1 beta (IL-1 beta) release from fresh and cultured colonic mucosa in patients with ulcerative colitis (UC) 30
Placebo-controlled trial of oral 5-ASA in relapse prevention of Crohn's disease 29
Interleukin 1 in ulcerative colitis 29
Topical treatment with 5-aminosalicylic in distal ulcerative colitis by using a new suppository preparation - A double-blind placebo controlled trial 29
Short report: zinc sulphate supplementation corrects abnormal erythrocyte membrane long‐chain fatty acid composition in patients with Crohn's disease 28
Spread and distribution of 5-ASA colonic foam and 5-ASA enema in patients with ulcerative colitis 22
p-ANCA and development of pouchitis in ulcerative colitis patients after proctocolectomy and ileoanal pouch anastomosis 22
Pentasa in maintenance treatment of ulcerative colitis 21
Steroid treatment in active Crohn's disease: a comparison between two regimens of different duration 19
Mucosal concentrations of interleukin-1β, interleukin-6, interleukin-8, and tumor necrosis factor-α in pelvic ileal pouches 19
MRI patterns in a case of 6-thioguanine-related hepatic sinusoidal obstruction syndrome 14
Totale 5.904
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.611
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.611
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020984 0 37 21 44 124 201 131 128 123 78 51 46
2020/2021858 109 68 74 38 32 57 37 34 93 48 69 199
2021/20221.230 42 42 58 95 83 47 41 51 129 106 349 187
2022/20231.608 146 248 121 176 95 125 70 106 280 43 103 95
2023/2024584 43 70 64 56 58 107 37 32 29 48 19 21
2024/2025113 111 2 0 0 0 0 0 0 0 0 0 0
Totale 5.904